Currently our health system follows ISMP recommendation of having basal insulin dispensed by pharmacy in a patient-specific barcoded syringe. We have recently upgraded our ADCs that will now print patient specific labels. We use these labels for the sliding scale/correctional fast acting insulin in the ADCs (much better process than old way with pharmacy flag labels).
There is a push to follow a similar process for the basal insulin and have in the ADC. The thought would be to have the long acting/basal insulin be stored within a locked lidded drawer requiring scan upon removal, labeling with patient specific label, non-overridable, not in manufacturer outer packaging, and scan upon return to address safety concerns/risks. What are other organizations doing? Have any varied from the current ISMP recommendation with the addition of safety measures?